VU T HO
Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology ST PETERSBURG, FL NPI 1871574871
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology FL Gilead Sciences, Inc. All categories
General Payments — all program years on this page
$2,924.37
- Category: General Payments
- Program years: PY2018–2024
- Record count: 146
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $848.14 across 36 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $848.14 | 36 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Gilead Sciences, Inc. | $85.70 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $81.27 | 3 |
| PFIZER INC. | $76.96 | 3 |
| TAIHO ONCOLOGY, INC. | $59.25 | 3 |
| Daiichi Sankyo Inc. | $59.04 | 2 |
| E.R. Squibb & Sons, L.L.C. | $54.46 | 3 |
| Fennec Pharmaceuticals, Inc. | $48.14 | 2 |
| Astellas Pharma US Inc | $46.99 | 2 |
| ABBVIE INC. | $33.84 | 1 |
| EISAI INC. | $31.73 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $31.38 | 1 |
| Merck Sharp & Dohme Corporation | $30.95 | 1 |
| Sumitomo Pharma America, Inc. | $25.52 | 1 |
| Incyte Corporation | $25.34 | 1 |
| PharmaEssentia USA Corporation | $24.01 | 1 |
| Dendreon Pharmaceuticals LLC | $23.80 | 1 |
| SpringWorks Therapeutics, Inc. | $22.44 | 1 |
| ARRAY BIOPHARMA INC | $20.69 | 1 |
| Novo Nordisk AS | $20.19 | 1 |
| Novocure Inc. | $17.93 | 1 |
| Genentech USA, Inc. | $15.40 | 1 |
| Janssen Pharmaceuticals, Inc | $13.11 | 1 |
By program year
Records — PY2024 (36)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.